• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Greenoaks Capital Partners Llc bought $20,389,447 worth of shares (918,789 units at $22.19) (SEC Form 4)

    5/14/24 9:00:25 PM ET
    $CPNG
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $CPNG alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    GREENOAKS CAPITAL PARTNERS LLC

    (Last) (First) (Middle)
    4 ORINDA WAY BUILDING C
    SUITE 200

    (Street)
    ORINDA CA 94563

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Coupang, Inc. [ CPNG ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) X Other (specify below)
    See Remarks
    3. Date of Earliest Transaction (Month/Day/Year)
    05/10/2024
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    Form filed by One Reporting Person
    X Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 05/10/2024 P 120,239 A $22.5306(1) 48,126,374 I See footnotes(2)(3)
    Class A Common Stock 05/13/2024 P 500,000 A $22.0599(4) 48,626,374 I See footnotes(2)(3)
    Class A Common Stock 05/14/2024 P 298,550 A $22.2758(5) 48,924,924 I See footnotes(2)(3)
    Class A Common Stock 51,396 D(3)(6)
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    1. Name and Address of Reporting Person*
    GREENOAKS CAPITAL PARTNERS LLC

    (Last) (First) (Middle)
    4 ORINDA WAY BUILDING C
    SUITE 200

    (Street)
    ORINDA CA 94563

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director 10% Owner
    Officer (give title below) X Other (specify below)
    See Remarks
    1. Name and Address of Reporting Person*
    MEHTA NEIL

    (Last) (First) (Middle)
    4 ORINDA WAY BUILDING C
    SUITE 200

    (Street)
    ORINDA CA 94563

    (City) (State) (Zip)

    Relationship of Reporting Person(s) to Issuer
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    Explanation of Responses:
    1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.505 to $22.575, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
    2. The securities reported herein are held by certain funds and accounts to which Greenoaks Capital Partners LLC ("Greenoaks Capital") serves as the investment adviser and related persons or entities, including the Reporting Persons and certain estate planning vehicles. Neil Mehta ("Mr. Mehta") serves as a Managing Director of Greenoaks Capital. Mr. Mehta is a director of the Issuer.
    3. Each Reporting Person disclaims beneficial ownership in the securities reported herein except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
    4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $21.825 to $22.20, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
    5. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.17 to $22.395, inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
    6. Represents vested and unvested restricted stock units held by Mr. Mehta for his service on the board of the Issuer.
    Remarks:
    Greenoaks Capital may be deemed to be a director by deputization for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, by virtue of the fact that Mr. Mehta currently serves on the board of directors of the Issuer.
    Greenoaks Capital Partners LLC, By: /s/ Neil Mehta, Managing Director 05/14/2024
    /s/ Neil Mehta 05/14/2024
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CPNG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CPNG

    DatePrice TargetRatingAnalyst
    2/26/2025$28.50Hold → Buy
    Deutsche Bank
    10/7/2024$30.00Underperform → Outperform
    Bernstein
    9/4/2024$18.00 → $31.00Hold → Outperform
    CLSA
    5/16/2024$26.00Neutral → Buy
    UBS
    5/3/2024$30.00Buy
    BofA Securities
    4/15/2024$19.00 → $26.00Neutral → Buy
    Citigroup
    2/29/2024$18.50 → $21.00Hold → Buy
    Deutsche Bank
    1/16/2024$20.00 → $17.00Buy → Neutral
    Citigroup
    More analyst ratings